Genesco (GCO) Q1 2027 earnings summary

Executive summary

• Q1 sales rose 3% year-over-year to $487 million, with comparable sales up 2% for the seventh consecutive positive quarter and e-commerce accounting for 24% of retail sales.

• Broad-based gains across all business segments, led by Journeys (+5%) and Johnston & Murphy (+7%), with strategic progress at schuh despite intentional comp declines.

• Gross margin improved to 47.0%, up 30 basis points, aided by reduced promotions and operational efficiencies.

• Adjusted operating loss improved by $4 million to $23.9 million; adjusted EBITDA loss was $10.6 million.

• Announced a new $40–$50 million cost savings program and raised full-year adjusted EPS outlook to $2.00–$2.40.

Financial highlights

• Q1 revenue increased 3% to $487 million, with adjusted gross margin at 47% (up 30 bps) and adjusted SG&A at 51.9% of sales (60 bps leverage).

• GAAP operating loss was $(15.4)M, non-GAAP operating loss $(23.9)M; GAAP EPS was $(1.42), non-GAAP EPS $(2.18).

• Inventory increased 6% year-over-year to $477M, mainly to support Journeys 4.0 expansion.

• Store count at quarter-end was 1,208, with 2 openings and 30 closures in Q1; 21 remodels completed.

• Trailing 12-month sales per square foot increased 9%.

Outlook and guidance

• Raised full-year adjusted EPS guidance to $2.00–$2.40, reflecting Q1 outperformance and a more cautious U.K. outlook.

• Full-year comparable sales growth expected at 1%-2%, with total sales flat to down 1% due to store closures and license exits.

• Gross margin projected to improve 50–60 basis points; adjusted operating income guidance increased to $34–$40 million.

• Q2 expected to be the most pressured quarter, with comps flat to slightly down and EPS $0.20–$0.30 lower year-over-year due to tax rate effects.

• CapEx planned at $65–$70M for the year, with 90–95% allocated to stores.